Alcon Inc (ALC) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Alcon inc   (NYSE: ALC)


Alcon Inc's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Alcon Inc's ROI in the fourth quarter of 2025?
Alcon inc achieved a return on average invested assets (ROI) of 4.25 % in its fourth quarter of 2025, which is below Alcon Inc's average return on investment, which stands at 4.86%.

ROI fell compared to the third quarter of 2025, despite the net income growth of % from the third quarter of 2025.

Within the Healthcare sector 208 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from to 2091.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM 4.57 % 3.33 % 2.59 % 2.43 % 1.67 %
Y / Y Net Income Change TTM -6.85 % -0.25 % -0.25 % 27.41 % 27.41 %
Investment (TTM) in Millions 27,393 27,393 26,723 27,393 26,533
Return On Investment (TTM) 4.25 % 4.42 % 4.49 % 4.7 % 4.77 %
ALC's Overall Ranking # 2091 # # # # 1765
Seq. Investment Change TTM 0.8 % 1.49 % 0.69 % 1.52 % -0.4 %
Seq. Net Income Change TTM -3.18 % 0 % -3.79 % 0 % 3.68 %
Net Income (TTM) in Millions 1,156 1,194 1,194 1,241 1,241

ALC Company Profile >> Back to ALC Roi Comparisons >> See Annual ALC Return On Investment



Return On Investment ALC's Ranking
Within: No.
Industry # 62
Sector # 209
Overall # 2091

Return On Investment Statistics
High Average Low
30.32 %
4.86 %
-2.92 %
(Dec 31 2010)   (Dec 31 2019)







Financial Statements
Alcon Inc's IV. Quarter Investments $ 27,393 Millions ALC's Balance sheet
Alcon Inc's IV. Quarter Income $ 980 Millions Quarterly ALC's Income Statement
ALC's Income by Division See ALC's Income by Division


ALC Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 27,393 26,533 26,954 26,660 25,811
Y / Y Investment Growth 3.24 % -1.56 % 1.1 % 3.29 % 1.32 %
Net Income in Millions 980 1,018 974 335 376
Y / Y Net Income Growth -3.73 % 4.52 % 190.75 % -10.9 % -
Annual Return On Investment 3.58 % 3.84 % 3.61 % 1.26 % 1.46 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 3.58 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ALC's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ALC's Competitors
Subscribers only: Roi for Alcon Inc's Suppliers
Subscribers only: Return On Investment for ALC's Customers

Other Ratios
ALC's Roa ALC's Inventory Turnover Ratio ALC's Growth Rates ALC's Dividend Statistics
ALC's Profitability Ratios ALC's Asset Turnover Ratio ALC's Dividend Growth
ALC's Roe ALC's Valuation Ratios ALC's Financial Strength Ratios ALC's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI
Nrc Health  11.33 %
Nephros Inc   11.27 %
3m Company  11.03 %
Pacific Health Care Organization Inc  10.98 %
Nature s Sunshine Products inc   10.95 %
Progyny Inc   10.84 %
Escalon Medical Corp   10.78 %
Qiagen N v   10.69 %
Cryoport inc   10.68 %
Siga Technologies Inc  10.57 %
Ligand Pharmaceuticals Incorporated  10.56 %
Healthcare Services Group Inc   10.55 %
Genmab A  10.37 %
Bristol myers Squibb Company  10.36 %
Brainsway Ltd   10.35 %
Kiniksa Pharmaceuticals International Plc  10.32 %
Penumbra Inc  10.30 %
Cypherpunk Technologies Inc   10.27 %
Lemaitre Vascular Inc   10.11 %
Alnylam Pharmaceuticals Inc   10.05 %
Align Technology inc   9.70 %
Haemonetics Corporation  9.62 %
Insulet Corporation  9.55 %
Viemed Healthcare Inc   9.53 %
Galapagos Nv  9.50 %
Utah Medical Products Inc  9.49 %
National Healthcare Corp  9.28 %
Profound Medical Corp   9.18 %
Abbott Laboratories  9.09 %
Edwards Lifesciences Corporation  9.02 %

Date modified: 2026-09-08T15:11:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.